Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease.

ABSTRACT:

Objective

History of cardiovascular diseases (CVDs) may influence the prognosis of patients hospitalised for COVID-19. We investigated whether patients with previous CVD have increased risk of death and major adverse cardiovascular event (MACE) when hospitalised for COVID-19.

Methods

We included 839 patients with COVID-19 hospitalised at the University Hospitals of Geneva. Demographic characteristics, medical history, laboratory values, ECG at admission and medications at admission were collected based on electronic medical records. The primary outcome was a composite of in-hospital mortality or MACE.

Results

Median age was 67 years, 453 (54%) were males and 277 (33%) had history of CVD. In total, 152 (18%) died and 687 (82%) were discharged, including 72 (9%) who sur

SUBMITTER: Tessitore E 

PROVIDER: S-EPMC8039226 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature